(Q37354233)

19 August 2017

title

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders (English)

1 reference

19 August 2017

0 references

0 references

Madaswamy S Muthu

1

1 reference

19 August 2017

Sanjay Singh

series ordinal

2

1 reference

19 August 2017

language of work or name

1 reference

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

4

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

105-118

1 reference

Nanotechnology: convergence with modern biology and medicine

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Biodegradable polymeric vectors for gene delivery to human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Multifunctional nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanoparticles--a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Magnetic nanoparticles and their applications in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Delivery of molecular and cellular medicine to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Organ targeting in vivo using phage display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

The role of mononuclear phagocytes in HTLV-III/LAV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Brain uptake of thiamine-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

The physiology of the lymphatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Solid lipid nanoparticles for targeted brain drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

A review of nanocarrier-based CNS delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Micellar nanocarriers: pharmaceutical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Amphiphilic block copolymers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Block copolymer micelles: preparation, characterization and application in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Polymeric micelles for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Cellular distribution of nonionic micelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Nanosystems for simultaneous imaging and drug delivery to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Dendrimers and antivirals: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Therapeutic and diagnostic applications of dendrimers for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Biodegradable, polymeric nanoparticle delivery systems for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Novel applications of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Designing of 'intelligent' liposomes for efficient delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Gold nanoparticles as carriers for efficient transmucosal insulin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Transferrin-mediated gold nanoparticle cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant Conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Clinical applications of magnetic drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

In vivo imaging of siRNA delivery and silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

The preparation of magnetic nanoparticles for applications in biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17435889.4.1.105

21 January 2018

Identifiers

DOI

10.2217/17435889.4.1.105

1 reference

19 August 2017

1 reference